The global sterility indicators market revenue was around US$ 980.4 million in 2022 and is estimated to reach US$ 2,611.4 million by 2031, growing at a compound annual growth rate (CAGR) of 11.5% during the forecast period from 2023 to 2031.
Sterility indicators are utilized to characterize or demonstrate how well a sterilization process is functioning. Sterilization is removing all living things as well as other biological or foreign agents, such as viruses, bacteria, prions, fungi, spore forms, and other species, from a specific region. Heat, chemicals, radiation, high pressure, and filtration are a few of the sterilization methods utilized.
Market Driving Factors
Extensive research and development (R&D) activities drive the market growth. R&D is estimated to drive demand for various sterilizing processes in the pharmaceutical and biotechnology industries. Pharmaceutical products and packing equipment must be sterilized to destroy all forms of microbiological life and safeguard against contamination.
An increase in cases of hospital-acquired infections drives the market growth. As a result, this has led dealers to grow their production rates to fulfill demand from the profitable healthcare industry. Infections developed in hospitals are understood to worsen the condition of previously admitted patients. This has increased the usage of hospital sterile processing worldwide.
The launch of new and cutting-edge sterility indicators boosts market growth. This is due to the increase in the number of infections around the world. Furthermore, the industry is likely to benefit from an increase in the geriatric population. Older people are more inclined to become unwell, which will certainly make market revenue due to their less immunity.
Disobedience to sterilization standards, high device prices, and chemical exposure can restrain market growth.
Regional Analysis
North America dominates the market. This is due to frequent product launches in medical devices and biologics, and refund coverage in the region. In addition, the increasing target patient population such as growing aging population is increasing the demand for medical products. Furthermore, the high prevalence of chronic diseases is increasing the adoption of cutting-edge treatment methods in the United States fuel the market growth. Additionally, the presence of few of the key players in the region is estimated to drive the market.
Asia-Pacific is estimated to dominate the market. This is because increase in the geriatric population, the surge in the awareness regarding usage of sterile devices or products, and an increase in the number of chronic diseases.
Segmentation Insights
Type Insight
The biological indicators segment is estimated to dominate the market. This is due to the broad range of applications of biological indicators in various types of sterilization processes. In addition, the increase in the usage of sterility indicators in pharmaceutical and biotechnology companies, hospitals, and research institutes fuel the segment growth.
Sterilization Process Insight
The ethylene oxide segment is predicted to dominate the market. This is due to the increase in the number of sterilization processes in hospitals, and the surge in the number of surgical procedures. Furthermore, chemical sterility indicators are generally utilized in ethylene oxide sterilization technology.
End User Insight
The hospital segment dominates the market. This segment is anticipated to continue leading as sterilization procedures are constantly carried out in hospitals. Furthermore, strict regulatory policies for sterilization of class III medical devices, drugs, and biologics are fueling the sterility indicators market.
Prominent Companies
Segmentation Outline
The global sterility indicators market segmentation focuses on Type, Sterilization Process, End User, and Region.
By Type
By Sterilization Process
By End User
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL STERILITY INDICATORS MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: STERILITY INDICATORS MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL STERILITY INDICATORS MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL STERILITY INDICATORS MARKET, BY TYPE
5.1 OVERVIEW
5.2 BIOLOGICAL INDICATORS
5.2.1 SELF CONTAINED VIALS
5.2.2 SPORE STRIPS
5.2.3 OTHERS
5.3 CHEMICAL INDICATORS
6 GLOBAL STERILITY INDICATORS MARKET, BY STERILIZATION PROCESS
6.1 OVERVIEW
6.2 STEAM
6.3 ETHYLENE OXIDE
6.4 DRY HEAT
6.5 OTHERS
7 GLOBAL STERILITY INDICATORS MARKET, BY END USER
7.1 OVERVIEW
7.2 HOSPITALS
7.3 PHARMACEUTICAL COMPANIES AND MEDICAL DEVICE COMPANIES
7.4 CLINICAL LABORATORIES AND RESEARCH CENTERS
8 GLOBAL STERILITY INDICATORS MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3.1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL STERILITY INDICATORS MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
9.4 COMPETITIVE DASHBOARD
9.5 PRODUCT MAPPING
9.6 TOP PLAYER POSITIONING, 2022
9.7 COMPETITIVE HEATMAP
9.8 TOP WINNING STRATEGIES
10 COMPANY PROFILES
10.1 CROSSTEX INTERNATIONAL INC
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.2 SIGMA ALDRICH
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.3 STRYKER CORPORATION
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.4 NELSON LABORATORIES LLC
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.5 NOXILIZER INC
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.6 MATACHANA GROUP
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.7 GETINGE AB
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.8 GKE GMBH
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.9 MMM GROUP
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.10 MESA LABS INC
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.11 ANDERSON PRODUCTS INC
10.11.1 OVERVIEW
10.11.2 FINANCIAL PERFORMANCE
10.11.3 PRODUCT OUTLOOK
10.11.4 KEY DEVELOPMENTS
10.11.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.12 PROPPER MANUFACTURING CO INC
10.12.1 OVERVIEW
10.12.2 FINANCIAL PERFORMANCE
10.12.3 PRODUCT OUTLOOK
10.12.4 KEY DEVELOPMENTS
10.12.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.13 3M
10.13.1 OVERVIEW
10.13.2 FINANCIAL PERFORMANCE
10.13.3 PRODUCT OUTLOOK
10.13.4 KEY DEVELOPMENTS
10.13.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.14 HU-FRIEDY MFG CO
10.14.1 OVERVIEW
10.14.2 FINANCIAL PERFORMANCE
10.14.3 PRODUCT OUTLOOK
10.14.4 KEY DEVELOPMENTS
10.14.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.15 STERIS PLC
10.15.1 OVERVIEW
10.15.2 FINANCIAL PERFORMANCE
10.15.3 PRODUCT OUTLOOK
10.15.4 KEY DEVELOPMENTS
10.15.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.16 FORTIVE CORPORATION
10.16.1 OVERVIEW
10.16.2 FINANCIAL PERFORMANCE
10.16.3 PRODUCT OUTLOOK
10.16.4 KEY DEVELOPMENTS
10.16.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.17 CARDINAL HEALTH INC
10.17.1 OVERVIEW
10.17.2 FINANCIAL PERFORMANCE
10.17.3 PRODUCT OUTLOOK
10.17.4 KEY DEVELOPMENTS
10.17.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved